Related references
Note: Only part of the references are listed.Germline MBD4 Mutations and Predisposition to Uveal Melanoma
Anne-Celine Derrien et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of Risk
Nakul Singh et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
Jose Maria Piulats et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma
Justine S. Paradis et al.
CLINICAL CANCER RESEARCH (2021)
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
Meredith S. Pelster et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer
Alexander C. Leeksma et al.
FRONTIERS IN ONCOLOGY (2021)
Splicing Patterns in SF3B1-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes
Jeremy Bigot et al.
CANCER DISCOVERY (2021)
Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C Inhibition
John J. Park et al.
CANCERS (2021)
Early reduction in ctDNA, regardless of best RECIST response, is associated with overall survival (OS) on tebentafusp in previously treated metastatic uveal melanoma (mUM) patients
A. N. Shoushtari et al.
ANNALS OF ONCOLOGY (2021)
Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma
Svenja Mergener et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Clinical characteristics of SF3B1 mutant (mut) uveal melanoma (UM) and response to immune checkpoint inhibition (ICI).
Joe Grimes et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma.
Jedd D. Wolchok et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Liquid Biopsy in Uveal Melanoma: Are We There Yet?
Eva Jin et al.
OCULAR ONCOLOGY AND PATHOLOGY (2021)
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)
Jason J. Luke et al.
CLINICAL CANCER RESEARCH (2020)
An Outcome Assessment of a Single Institution's Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis
Rino S. Seedor et al.
CANCERS (2020)
A phase II study of ERK inhibition by ulixertinib (BVD-523) in metastatic uveal melanoma.
Elizabeth Iannotti Buchbinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy.
Shaheer Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A randomized phase II study of adjuvant sunitinib or valproic acid in high-risk patients with uveal melanoma.
Takami Sato et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
Peter A. Johansson et al.
NATURE COMMUNICATIONS (2020)
Molecular profiling of driver events in metastatic uveal melanoma
Joakim Karlsson et al.
NATURE COMMUNICATIONS (2020)
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal Melanoma
Florencia Rago et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma
Mark R. Middleton et al.
CLINICAL CANCER RESEARCH (2020)
Germline loss-of-function variants in MBD4 are rare in Finnish patients with uveal melanoma
Pauliina Repo et al.
PIGMENT CELL & MELANOMA RESEARCH (2020)
ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer
Aileen Patricia Szczepanski et al.
GENOME MEDICINE (2020)
Treatment of Metastatic Uveal Melanoma: Systematic Review
Cristina Rodriguez-Vidal et al.
CANCERS (2020)
Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma
Fabiana Mallone et al.
CANCERS (2020)
The biological function and clinical significance of SF3B1 mutations in cancer
Zhixia Zhou et al.
BIOMARKER RESEARCH (2020)
Comprehensive analysis of cutaneous and uveal melanoma liver metastases
Esmee P. Hoefsmit et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
BAP1: Not just a BRCA1-associated protein
Bryan H. Louie et al.
CANCER TREATMENT REVIEWS (2020)
Gene Expression Profiling in Uveal Melanoma: Five-Year Prospective Outcomes and Meta-Analysis
Thomas M. Aaberg et al.
OCULAR ONCOLOGY AND PATHOLOGY (2020)
Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling
Amy C. Schefler et al.
MELANOMA MANAGEMENT (2020)
Risk-stratified systemic surveillance in uveal melanoma
Jacquelyn M. Davanzo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
Xiaodong Feng et al.
CANCER CELL (2019)
Structure-Activity Relationship Studies of the Natural Product Gq/11 Protein Inhibitor YM-254890
Xiao-Feng Xiong et al.
CHEMMEDCHEM (2019)
Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab
Peter A. Johansson et al.
IMMUNOGENETICS (2019)
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
Raunak Shrestha et al.
GENOME MEDICINE (2019)
Adjuvant Ipilimumab in High-Risk Uveal Melanoma
Eric Fountain et al.
CANCERS (2019)
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
Henrik Jespersen et al.
BMC CANCER (2019)
Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D
Pornpattana Vichitvejpaisal et al.
OPHTHALMOLOGY (2019)
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
L. Khoja et al.
ANNALS OF ONCOLOGY (2019)
HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma
Fernanda Faiao-Flores et al.
CLINICAL CANCER RESEARCH (2019)
Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations
Manuel Rodrigues et al.
CLINICAL CANCER RESEARCH (2019)
The genetic evolution of metastatic uveal melanoma
A. Hunter Shain et al.
NATURE GENETICS (2019)
Immunotherapies for the Treatment of Uveal Melanoma-History and Future
Timo E. Schank et al.
CANCERS (2019)
Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
Michela Croce et al.
CANCERS (2019)
Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry
Anouk Jochems et al.
CANCERS (2019)
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
Kartik Anand et al.
CANCERS (2019)
Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
Raquel Vivet-Noguer et al.
CANCERS (2019)
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project
Mathieu E. Bakhoum et al.
CANCERS (2019)
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
Jia Yi Fong et al.
CANCER CELL (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?
Christiaan van Weeghel et al.
CANCERS (2019)
A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
K. Fizazi et al.
ANNALS OF ONCOLOGY (2019)
LBA71Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study)
H Jespersen et al.
ANNALS OF ONCOLOGY (2019)
A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision
Mitchell S. Stark et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2019)
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Markus Heppt et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
Kalijn Fredrike Bol et al.
CANCERS (2019)
Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells
Laurence Booth et al.
CANCER BIOLOGY & THERAPY (2019)
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
Vivian Chua et al.
EMBO MOLECULAR MEDICINE (2019)
Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis
Elina S. Rantala et al.
MELANOMA RESEARCH (2019)
Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma
Dominic Lapadula et al.
MOLECULAR CANCER RESEARCH (2019)
EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC
Gnana P. Krishnamoorthy et al.
CANCER DISCOVERY (2019)
A Phase I trial of LXS196, a novel PKC inhibitor for metastatic uveal melanoma
Ellen Kapiteijn et al.
CANCER RESEARCH (2019)
The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence
Marilita M. Moschos et al.
ANTICANCER RESEARCH (2018)
Pathogenic Germline Variants in 10,389 Adult Cancers
Kuan-lin Huang et al.
CELL (2018)
Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy
Phoebe Star et al.
EUROPEAN JOURNAL OF CANCER (2018)
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
Richard D. Carvajal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler et al.
NATURE MEDICINE (2018)
Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma Comparison with Institutional Controls
Matias E. Valsecchi et al.
OPHTHALMOLOGY (2018)
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
Manuel Rodrigues et al.
NATURE COMMUNICATIONS (2018)
Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Didier Decaudin et al.
Oncotarget (2018)
Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma
Anne Marie Lane et al.
JAMA OPHTHALMOLOGY (2018)
Continued Poor Survival in Metastatic Uveal Melanoma Implications for Molecular Prognostication, Surveillance Imaging, Adjuvant Therapy, and Clinical Trials
Douglas B. Johnson et al.
JAMA OPHTHALMOLOGY (2018)
Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma
Louis Cai et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma
Theresa Steeb et al.
EUROPEAN JOURNAL OF CANCER (2018)
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
Sebastian Walpole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Minimal functional driver gene heterogeneity among untreated metastases
Johannes G. Reiter et al.
SCIENCE (2018)
Targeting nucleotide exchange to inhibit constitutively active G protein a subunits in cancer cells
Michael D. Onken et al.
SCIENCE SIGNALING (2018)
Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma
K. G. Ewens et al.
BMC CANCER (2018)
Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013)
Mary E. Aronow et al.
OCULAR ONCOLOGY AND PATHOLOGY (2018)
Treatment of uveal melanoma: where are we now?
Jessica Yang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma
Babak Masoomian et al.
JOURNAL OF CURRENT OPHTHALMOLOGY (2018)
STREAM: A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (5) treatment of chemonaive patients (pts) with metastatic uveal melanoma (MUM).
Max E. Scheulen et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas
Dariush Etemadmoghadam et al.
CANCER RESEARCH (2017)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor
Yun Wang et al.
CANCER LETTERS (2017)
Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases
K. Rai et al.
CLINICAL GENETICS (2016)
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4
Peter Johansson et al.
ONCOTARGET (2016)
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing
Beryl Royer-Bertrand et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Clinical Outcomes in Metastatic Uveal Melanoma Treated With PD-1 and PD-L1 Antibodies
Alain P. Algazi et al.
CANCER (2016)
ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma
Jae Hyuk Yoo et al.
CANCER CELL (2016)
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma
Alexander N. Shoushtari et al.
MELANOMA RESEARCH (2016)
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
Amanda R. Moore et al.
NATURE GENETICS (2016)
Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status
Marie Schoumacher et al.
NATURE MEDICINE (2016)
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis
Deborah Kuk et al.
ONCOLOGIST (2016)
BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma
Joni A. Turunen et al.
OPHTHALMOLOGY (2016)
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma
Kalijn F. Bol et al.
OPHTHALMOLOGY (2016)
Uveal Melanomas with SF3B1 Mutations A Distinct Subclass Associated with Late-Onset Metastases
Serdar Yavuzyigitoglu et al.
OPHTHALMOLOGY (2016)
The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma
Nabil Amirouchene-Angelozzi et al.
ONCOTARGET (2016)
Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
Guillaume Carita et al.
ONCOTARGET (2016)
Increased Levels of miRNA-146a in Serum and Histologic Samples of Patients with Uveal Melanoma
Andrea Russo et al.
FRONTIERS IN PHARMACOLOGY (2016)
Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study
Kristen Meldi Plasseraud et al.
JOURNAL OF ONCOLOGY (2016)
Meta-analysis of phase II trials in metastatic uveal melanoma (MUM) to determine progression-free (PFS) and overall survival (OS) benchmarks for future phase II trials: An irci-ocular melanoma initiative.
Leila Khoja et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Frequency and Implications of Discordant Gene Expression Profile Class in Posterior Uveal Melanomas Sampled by Fine Needle Aspiration Biopsy
James J. Augsburger et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications
Marco Ragusa et al.
CANCER BIOLOGY & THERAPY (2015)
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Alan Serrels et al.
CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Uveal melanoma: Estimating prognosis
Swathi Kaliki et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2015)
Loss of BAP1 function leads to EZH2-dependent transformation
Lindsay M. LaFave et al.
NATURE MEDICINE (2015)
The experimental power of FR900359 to study Gq-regulated biological processes
Ramona Schrage et al.
NATURE COMMUNICATIONS (2015)
BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
Grazia Ambrosini et al.
ONCOTARGET (2015)
Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations
Mrinali P. Gupta et al.
JAMA OPHTHALMOLOGY (2015)
Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma
Gaia Barisione et al.
JAMA OPHTHALMOLOGY (2015)
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
Mizue Terai et al.
EBIOMEDICINE (2015)
MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma
Maria Eldh et al.
BMC CANCER (2014)
Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
Xiaodong Feng et al.
CANCER CELL (2014)
Expanding the Clinical Phenotype of Hereditary BAP1 Cancer Predisposition Syndrome, Reporting Three New Cases
Robert Pilarski et al.
GENES CHROMOSOMES & CANCER (2014)
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
Francois-Clement Bidard et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma A Randomized Clinical Trial
Richard D. Carvajal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection
D. Gomez et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
The Phosphoinositide 3-Kinase α Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells
Elgilda Musi et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease
Susan Achberger et al.
MOLECULAR IMMUNOLOGY (2014)
Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines
Mario Venza et al.
TUMORI JOURNAL (2014)
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method
Cinzia Mazzini et al.
CANCERS (2014)
Chromosome 3 Status Combined With BAP1 and EIF1AX Mutation Profiles Are Associated With Metastasis in Uveal Melanoma
Kathryn G. Ewens et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
Identification of Circulating Melanoma Cells in Uveal Melanoma Patients by Dual-Marker Immunoenrichment
Ayseguel Tura et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma.
Sophie Piperno-Neumann et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The Importance of Multidisciplinary Approach in Early Detection of BAP1 Tumor Predisposition Syndrome: Clinical Management and Risk Assessment
Angelo Battaglia
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2014)
Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses
Thomas M. Aaberg et al.
CLINICAL OPHTHALMOLOGY (2014)
MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients
Ernie Marshall et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors
Ferry A. L. M. Eskens et al.
CLINICAL CANCER RESEARCH (2013)
Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer
Shelby D. Reed et al.
GENETICS IN MEDICINE (2013)
Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model
Oliver Surriga et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
Marcel Martin et al.
NATURE GENETICS (2013)
American Joint Committee on Cancer Classification of Posterior Uveal Melanoma (Tumor Size Category) Predicts Prognosis in 7731 Patients
Carol L. Shields et al.
OPHTHALMOLOGY (2013)
Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases
Lauren G. Aoude et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Radiation-Related Cancer Risk Associated With Surveillance Imaging for Metastasis From Choroidal Melanoma
Joanne C. Wen et al.
JAMA OPHTHALMOLOGY (2013)
Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma
Claudia H. D. Metz et al.
CANCER MEDICINE (2013)
Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
Solange Landreville et al.
CLINICAL CANCER RESEARCH (2012)
Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma
John M. Kirkwood et al.
CLINICAL CANCER RESEARCH (2012)
Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner
Jahan S. Khalili et al.
CLINICAL CANCER RESEARCH (2012)
Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma
Jordan Madic et al.
CLINICAL CANCER RESEARCH (2012)
Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival
Mohamed H. Abdel-Rahman et al.
EXPERIMENTAL EYE RESEARCH (2012)
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Michele Carbone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Gerald S. Falchook et al.
LANCET ONCOLOGY (2012)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study
Victoria Orcurto et al.
MELANOMA RESEARCH (2012)
A pilot study of sunitinib malate in patients with metastatic uveal melanoma
Amit Mahipal et al.
MELANOMA RESEARCH (2012)
Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma
Michael D. Onken et al.
OPHTHALMOLOGY (2012)
The genetics of uveal melanoma: an emerging framework for targeted therapy
J. William Harbour
PIGMENT CELL & MELANOMA RESEARCH (2012)
Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families
Ching-Ni Jenny Njauw et al.
PLOS ONE (2012)
Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512
Shailender Bhatia et al.
PLOS ONE (2012)
Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting
J. U. Blohmer et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Cost-effectiveness of a chemotherapy predictive test
Anne-Lise Vataire et al.
BULLETIN DU CANCER (2012)
Higher Percentage of FISH-Determined Monosomy 3 and 8q Amplification in Uveal Melanoma Cells relate to Poor Patient Prognosis
Thomas van den Bosch et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Radioembolization as Salvage Therapy for Hepatic Metastasis of Uveal Melanoma: A Single-Institution Experience
Carin F. Gonsalves et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Uveal Melanoma: Trends in Incidence, Treatment, and Survival
Arun D. Singh et al.
OPHTHALMOLOGY (2011)
Hepatic Artery Chemoembolization in Patients With Ocular Melanoma Metastatic to the Liver Response, Survival, and Prognostic Factors
Sanjay Gupta et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
Transarterial chemoembolization of liver metastases in patients with uveal melanoma
P. E. Huppert et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
Johanna C. Scheuermann et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Mutations in GNA11 in Uveal Melanoma.
Catherine D. Van Raamsdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Effectiveness of Treatments for Metastatic Uveal Melanoma
James J. Augsburger et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes
Carol L. Shields et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma
J. Bauer et al.
BRITISH JOURNAL OF CANCER (2009)
Surgical management of liver metastases from uveal melanoma: 1.6 years' experience at the Institut Curie
P. Mariani et al.
EJSO (2009)
Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research
S. A. Cook et al.
EYE (2009)
Reactions to and Desire for Prognostic Testing in Choroidal Melanoma Patients
Tammy M. Beran et al.
JOURNAL OF GENETIC COUNSELING (2009)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis
Shu-Hong Chang et al.
MELANOMA RESEARCH (2008)
Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma
Michael D. Onken et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study
S. A. Callejo et al.
EYE (2007)
Clinical and cytogenetic analyses in uveal melanoma
Emine Kilic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study
K Patel et al.
MELANOMA RESEARCH (2005)
Dissecting karyotypic patterns in malignant melanomas: Temporal clustering of losses and gains in melanoma karyotypic evolution
M Hoglund et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Prolonged survival after complete resection of metastases from intraocular melanoma
EC Hsueh et al.
CANCER (2004)
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death
MD Onken et al.
CANCER RESEARCH (2004)
Very long-term prognosis of patients with malignant uveal melanoma
E Kujala et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
MEK inhibition enhances paclitaxel-induced tumor apoptosis
JP MacKeigan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
